MINI-FOCUS: CELL-BASED THERAPY
Myogenic Endothelial Cells Purified From Human Skeletal Muscle Improve Cardiac Function After Transplantation Into Infarcted Myocardium
Masaho Okada, MD*, ,
Thomas R. Payne, PhD*, ,||,
Bo Zheng, MD*, ,
Hideki Oshima, MD, PhD*, ,
Nobuo Momoi, MD ,
Kimimasa Tobita, MD ,||,
Bradley B. Keller, MD ,
Julie A. Phillippi, PhD*,¶,
Bruno Péault, PhD*, and
Johnny Huard, PhD*, , ,||,*
* Stem Cell Research Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
Department of Pediatrics, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
|| Department of Bioengineering, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
¶ Carnegie Mellon University, Pittsburgh, Pennsylvania
Manuscript received April 21, 2008;
revised manuscript received July 16, 2008,
accepted July 21, 2008.
* Reprint requests and correspondence: Dr. Johnny Huard, Stem Cell Research Center, 4100 Rangos Research Center, 3460 Fifth Avenue, Pittsburgh, Pennsylvania 15213 (Email: jhuard{at}pitt.edu).
Objectives: The aim of this study was to evaluate the therapeutic potential of human skeletal muscle-derived myoendothelial cells for myocardial infarct repair.
Background: We have recently identified and purified a novel population of myoendothelial cells from human skeletal muscle. These cells coexpress myogenic and endothelial cell markers and produce robust muscle regeneration when injected into cardiotoxin-injured skeletal muscle.
Methods: Myoendothelial cells were isolated from biopsies of human skeletal muscle using a fluorescence-activated cell sorter along with populations of regular myoblasts and endothelial cells. Acute myocardial infarction was induced in male immune-deficient mice, and cells were directly injected into the ischemic area. Cardiac function was assessed by echocardiography, and donor cell engraftment, angiogenesis, scar tissue, endogenous cardiomyocyte proliferation, and apoptosis were all evaluated by immunohistochemistry.
Results: A greater improvement in left ventricular function was observed after intramyocardial injection of myoendothelial cells when compared with that seen in hearts injected with myoblast or endothelial cells. Transplanted myoendothelial cells generated robust engraftments within the infarcted myocardium, and also stimulated angiogenesis, attenuation of scar tissue, and proliferation and survival of endogenous cardiomyocytes more effectively than transplanted myoblasts or endothelial cells.
Conclusions: Our findings suggest that myoendothelial cells represent a novel cell population from human skeletal muscle that may hold promise for cardiac repair.
Key Words: human stem cells myocardial infarction paracrine factors skeletal muscle VEGF
|
Abbreviations and Acronyms
| | cTnI = cardiac-specific isoforms of troponin I | | cTnT = cardiac-specific isoforms of troponin T | | DMEM = Dulbecco's modified Eagle's medium | | EDA = end-diastolic area | | ELISA = enzyme-linked immunoadsorbent assay | | FAC = fractional area change | | FACS = fluorescence-activated cell sorting | | FBS = fetal bovine serum | | fskMyHC = fast skeletal myosin heavy chain | | LV = left ventricle/ventricular | | MDSC = muscle-derived stem cell | | MI = myocardial infarction | | nLacZ
= nuclear LacZ | | PBS = phosphate-buffered saline | | PCNA = proliferating cell nuclear antigen | | qPCR = quantitative real-time polymerase chain reaction | | SkM = skeletal myoblast | | TUNEL = terminal dUPT nick end-labeling | | VEGF = vascular endothelial growth factor |
|
Related Articles
-
Skeletal Myoblasts for Cardiac Repair: Act II?
- Philippe Menasché
J. Am. Coll. Cardiol. 2008 52: 1881-1883.
[Full Text]
[PDF]
-
Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 52: A40.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
P. Menasche
Skeletal Myoblasts for Cardiac Repair: Act II?
J. Am. Coll. Cardiol.,
December 2, 2008;
52(23):
1881 - 1883.
[Full Text]
[PDF]
|
 |
|
|